HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-DEC-10 3Q0Z TITLE CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA TITLE 2 POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7- TITLE 3 DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) TITLE 4 CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NS5B, P68; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS SUBTYPE 1B; SOURCE 3 ORGANISM_TAXID: 31647; SOURCE 4 STRAIN: BARTENSCHLAGER; SOURCE 5 GENE: NS5B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS NS5B, POLYMERASE, HCV, FINGERS, PALM, THUMB, TRANSFERASE, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 3 13-SEP-23 3Q0Z 1 REMARK SEQADV REVDAT 2 11-MAY-11 3Q0Z 1 JRNL REVDAT 1 27-APR-11 3Q0Z 0 JRNL AUTH X.ZHENG,T.W.HUDYMA,S.W.MARTIN,C.BERGSTROM,M.DING,F.HE, JRNL AUTH 2 J.ROMINE,M.A.POSS,J.F.KADOW,C.H.CHANG,J.WAN,M.R.WITMER, JRNL AUTH 3 P.MORIN,D.M.CAMAC,S.SHERIFF,B.R.BENO,K.L.RIGAT,Y.K.WANG, JRNL AUTH 4 R.FRIDELL,J.LEMM,D.QIU,M.LIU,S.VOSS,L.PELOSI,S.B.ROBERTS, JRNL AUTH 5 M.GAO,J.KNIPE,R.G.GENTLES JRNL TITL SYNTHESES AND INITIAL EVALUATION OF A SERIES OF INDOLO-FUSED JRNL TITL 2 HETEROCYCLIC INHIBITORS OF THE POLYMERASE ENZYME (NS5B) OF JRNL TITL 3 THE HEPATITIS C VIRUS. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2925 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21486696 JRNL DOI 10.1016/J.BMCL.2011.03.067 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 62918 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.460 REMARK 3 FREE R VALUE TEST SET COUNT : 919 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.92 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4667 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2314 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4610 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE : 0.2645 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 57 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8480 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 509 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.93140 REMARK 3 B22 (A**2) : 3.73570 REMARK 3 B33 (A**2) : 7.19570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.281 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8812 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 11978 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 2990 ; 2.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 163 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 1306 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 8812 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1154 ; 5.000 ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 10313 ; 4.000 ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.65 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3Q0Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063057. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63158 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 8.900 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.79900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1C2P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.15000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 115.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.15000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -118.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 66.30000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -45.70000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.85000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 GLU A 17 REMARK 465 GLU A 18 REMARK 465 THR A 19 REMARK 465 LYS A 20 REMARK 465 LEU A 21 REMARK 465 PRO A 22 REMARK 465 ILE A 23 REMARK 465 ASN A 24 REMARK 465 ALA A 25 REMARK 465 LEU A 26 REMARK 465 SER A 27 REMARK 465 ASN A 28 REMARK 465 SER A 29 REMARK 465 LEU A 30 REMARK 465 LEU A 31 REMARK 465 ARG A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 ASN A 35 REMARK 465 LEU A 36 REMARK 465 MET B 0 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 GLU B 17 REMARK 465 GLU B 18 REMARK 465 THR B 19 REMARK 465 LYS B 20 REMARK 465 LEU B 21 REMARK 465 PRO B 22 REMARK 465 ILE B 23 REMARK 465 ASN B 24 REMARK 465 ALA B 25 REMARK 465 LEU B 26 REMARK 465 SER B 27 REMARK 465 ASN B 28 REMARK 465 SER B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 ARG B 32 REMARK 465 HIS B 33 REMARK 465 HIS B 34 REMARK 465 ASN B 35 REMARK 465 LEU B 36 REMARK 465 ARG B 568 REMARK 465 PRO B 569 REMARK 465 ARG B 570 REMARK 465 TRP B 571 REMARK 465 PHE B 572 REMARK 465 MET B 573 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 37 CG1 CG2 REMARK 470 LEU A 57 CG CD1 CD2 REMARK 470 LYS A 100 CD CE NZ REMARK 470 GLU A 131 CG CD OE1 OE2 REMARK 470 VAL A 147 CG1 CG2 REMARK 470 LYS A 355 CG CD CE NZ REMARK 470 LYS A 535 CE NZ REMARK 470 ARG A 568 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 37 CG1 CG2 REMARK 470 LEU B 57 CG CD1 CD2 REMARK 470 LYS B 90 CD CE NZ REMARK 470 LYS B 100 CD CE NZ REMARK 470 GLU B 131 CG CD OE1 OE2 REMARK 470 VAL B 147 CG1 CG2 REMARK 470 LYS B 355 CG CD CE NZ REMARK 470 LYS B 535 CG CD CE NZ REMARK 470 ARG B 566 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 131 -31.60 -131.96 REMARK 500 LEU A 260 -56.99 -124.46 REMARK 500 SER A 347 60.97 70.24 REMARK 500 ALA A 348 55.45 -157.51 REMARK 500 ILE A 424 -60.18 -98.58 REMARK 500 PHE A 551 66.90 -118.80 REMARK 500 TYR A 555 25.32 -140.43 REMARK 500 ARG A 568 76.09 61.80 REMARK 500 LEU B 260 -56.89 -126.21 REMARK 500 SER B 347 61.27 70.59 REMARK 500 ALA B 348 54.60 -157.37 REMARK 500 ILE B 424 -61.15 -97.75 REMARK 500 LEU B 536 89.00 73.22 REMARK 500 PHE B 551 66.59 -118.32 REMARK 500 TYR B 555 24.77 -140.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 23E A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 651 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 652 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 653 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 654 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 655 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 23E B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 651 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 652 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 653 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 656 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 657 DBREF 3Q0Z A 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992 DBREF 3Q0Z B 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992 SEQADV 3Q0Z MET A 0 UNP Q9WMX2 INITIATING METHIONINE SEQADV 3Q0Z MET B 0 UNP Q9WMX2 INITIATING METHIONINE SEQRES 1 A 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 A 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA SEQRES 3 A 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 A 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS SEQRES 5 A 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 A 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 A 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 A 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR SEQRES 9 A 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL SEQRES 10 A 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 A 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 A 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 A 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 A 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 A 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 A 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA SEQRES 17 A 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP SEQRES 18 A 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 A 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 A 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG SEQRES 21 A 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN SEQRES 22 A 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 A 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 A 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 A 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 A 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG SEQRES 27 A 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 A 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 A 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 A 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 A 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 A 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 A 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 A 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 A 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 A 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS SEQRES 37 A 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 A 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 A 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 A 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 A 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 A 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU SEQRES 43 A 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY SEQRES 44 A 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP SEQRES 45 A 574 PHE MET SEQRES 1 B 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 B 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA SEQRES 3 B 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 B 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS SEQRES 5 B 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 B 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 B 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 B 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR SEQRES 9 B 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL SEQRES 10 B 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 B 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 B 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 B 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 B 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 B 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 B 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA SEQRES 17 B 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP SEQRES 18 B 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 B 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 B 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG SEQRES 21 B 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN SEQRES 22 B 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 B 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 B 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 B 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 B 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG SEQRES 27 B 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 B 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 B 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 B 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 B 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 B 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 B 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 B 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 B 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 B 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS SEQRES 37 B 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 B 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 B 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 B 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 B 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 B 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU SEQRES 43 B 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY SEQRES 44 B 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP SEQRES 45 B 574 PHE MET HET 23E A 601 47 HET SO4 A 651 5 HET SO4 A 652 5 HET SO4 A 653 5 HET SO4 A 654 5 HET SO4 A 655 5 HET 23E B 601 47 HET SO4 B 651 5 HET SO4 B 652 5 HET SO4 B 653 5 HET SO4 B 656 5 HET SO4 B 657 5 HETNAM 23E (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H- HETNAM 2 23E INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) HETNAM 3 23E CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP- HETNAM 4 23E 2-ENOIC ACID HETNAM SO4 SULFATE ION FORMUL 3 23E 2(C38 H38 N4 O5) FORMUL 4 SO4 10(O4 S 2-) FORMUL 15 HOH *509(H2 O) HELIX 1 1 THR A 41 ARG A 43 5 3 HELIX 2 2 SER A 44 THR A 53 1 10 HELIX 3 3 ASP A 61 SER A 76 1 16 HELIX 4 4 SER A 84 LEU A 91 1 8 HELIX 5 5 GLY A 104 ASN A 110 1 7 HELIX 6 6 SER A 112 ASP A 129 1 18 HELIX 7 7 ASP A 164 GLY A 188 1 25 HELIX 8 8 SER A 189 TYR A 195 5 7 HELIX 9 9 SER A 196 ALA A 210 1 15 HELIX 10 10 CYS A 223 VAL A 228 1 6 HELIX 11 11 THR A 229 GLN A 241 1 13 HELIX 12 12 ALA A 246 LEU A 260 1 15 HELIX 13 13 THR A 286 ALA A 306 1 21 HELIX 14 14 GLY A 328 TYR A 346 1 19 HELIX 15 15 ASP A 359 ILE A 363 5 5 HELIX 16 16 PRO A 388 ARG A 401 1 14 HELIX 17 17 ASN A 406 TYR A 415 1 10 HELIX 18 18 THR A 418 ILE A 424 1 7 HELIX 19 19 ILE A 424 GLU A 437 1 14 HELIX 20 20 GLU A 455 LEU A 457 5 3 HELIX 21 21 ASP A 458 GLY A 468 1 11 HELIX 22 22 LEU A 469 SER A 473 5 5 HELIX 23 23 SER A 478 LEU A 492 1 15 HELIX 24 24 PRO A 496 GLN A 514 1 19 HELIX 25 25 GLY A 515 PHE A 526 1 12 HELIX 26 26 ASN A 527 VAL A 530 5 4 HELIX 27 27 ILE A 539 SER A 543 5 5 HELIX 28 28 THR B 41 ARG B 43 5 3 HELIX 29 29 SER B 44 THR B 53 1 10 HELIX 30 30 ASP B 61 SER B 76 1 16 HELIX 31 31 SER B 84 LEU B 91 1 8 HELIX 32 32 GLY B 104 ASN B 110 1 7 HELIX 33 33 SER B 112 ASP B 129 1 18 HELIX 34 34 ASP B 164 GLY B 188 1 25 HELIX 35 35 SER B 189 TYR B 195 5 7 HELIX 36 36 SER B 196 ALA B 210 1 15 HELIX 37 37 CYS B 223 VAL B 228 1 6 HELIX 38 38 THR B 229 GLN B 241 1 13 HELIX 39 39 ALA B 246 LEU B 260 1 15 HELIX 40 40 THR B 286 ALA B 306 1 21 HELIX 41 41 GLY B 328 TYR B 346 1 19 HELIX 42 42 ASP B 359 ILE B 363 5 5 HELIX 43 43 PRO B 388 ARG B 401 1 14 HELIX 44 44 ASN B 406 TYR B 415 1 10 HELIX 45 45 THR B 418 ILE B 424 1 7 HELIX 46 46 ILE B 424 GLU B 437 1 14 HELIX 47 47 GLU B 455 LEU B 457 5 3 HELIX 48 48 ASP B 458 GLY B 468 1 11 HELIX 49 49 LEU B 469 SER B 473 5 5 HELIX 50 50 SER B 478 LEU B 492 1 15 HELIX 51 51 PRO B 496 GLN B 514 1 19 HELIX 52 52 GLY B 515 PHE B 526 1 12 HELIX 53 53 ASN B 527 VAL B 530 5 4 HELIX 54 54 ILE B 539 SER B 543 5 5 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N ILE A 138 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O ILE A 160 N MET A 139 SHEET 1 B 2 TYR A 38 ALA A 39 0 SHEET 2 B 2 VAL A 144 PHE A 145 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 CYS A 316 -1 N THR A 312 O ILE A 323 SHEET 1 D 2 ASN A 369 HIS A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O TYR A 383 N SER A 371 SHEET 1 E 3 LEU A 443 ILE A 447 0 SHEET 2 E 3 ALA A 450 ILE A 454 -1 O TYR A 452 N CYS A 445 SHEET 3 E 3 TYR A 561 SER A 563 1 O HIS A 562 N CYS A 451 SHEET 1 F 2 LEU A 545 ASP A 546 0 SHEET 2 F 2 SER A 565 ARG A 566 -1 O SER A 565 N ASP A 546 SHEET 1 G 5 TYR B 4 TRP B 6 0 SHEET 2 G 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5 SHEET 3 G 5 GLY B 264 THR B 267 -1 N LEU B 266 O GLY B 275 SHEET 4 G 5 THR B 136 ALA B 140 1 N ILE B 138 O THR B 267 SHEET 5 G 5 LEU B 159 PHE B 162 -1 O ILE B 160 N MET B 139 SHEET 1 H 2 TYR B 38 ALA B 39 0 SHEET 2 H 2 VAL B 144 PHE B 145 -1 O PHE B 145 N TYR B 38 SHEET 1 I 3 PRO B 214 TYR B 219 0 SHEET 2 I 3 ASP B 319 GLU B 325 -1 O CYS B 324 N MET B 215 SHEET 3 I 3 GLN B 309 CYS B 316 -1 N THR B 312 O ILE B 323 SHEET 1 J 2 ASN B 369 HIS B 374 0 SHEET 2 J 2 ARG B 380 THR B 385 -1 O THR B 385 N ASN B 369 SHEET 1 K 3 LEU B 443 ILE B 447 0 SHEET 2 K 3 ALA B 450 ILE B 454 -1 O ILE B 454 N LEU B 443 SHEET 3 K 3 TYR B 561 SER B 563 1 O HIS B 562 N CYS B 451 SHEET 1 L 2 LEU B 545 ASP B 546 0 SHEET 2 L 2 SER B 565 ARG B 566 -1 O SER B 565 N ASP B 546 SITE 1 AC1 15 LEU A 392 ALA A 395 ALA A 396 ILE A 424 SITE 2 AC1 15 HIS A 428 LEU A 492 GLY A 493 VAL A 494 SITE 3 AC1 15 PRO A 495 PRO A 496 ARG A 498 VAL A 499 SITE 4 AC1 15 ARG A 503 23E B 601 HOH B 717 SITE 1 AC2 5 SER A 84 VAL A 85 ARG A 120 HOH A 757 SITE 2 AC2 5 HOH A 763 SITE 1 AC3 6 ARG A 48 LYS A 51 THR A 221 ARG A 222 SITE 2 AC3 6 CYS A 223 HOH A 808 SITE 1 AC4 5 HIS A 374 SER A 476 GLY A 516 ARG A 517 SITE 2 AC4 5 HOH A 760 SITE 1 AC5 5 PRO A 496 LEU A 497 ARG A 498 ARG A 570 SITE 2 AC5 5 HOH A 803 SITE 1 AC6 5 SER A 371 SER A 478 LYS A 523 HOH A 849 SITE 2 AC6 5 HOH A 944 SITE 1 AC7 18 ALA A 400 ARG A 401 HIS A 428 23E A 601 SITE 2 AC7 18 LEU B 392 ALA B 395 ALA B 396 ILE B 424 SITE 3 AC7 18 HIS B 428 LEU B 492 GLY B 493 VAL B 494 SITE 4 AC7 18 PRO B 495 PRO B 496 ARG B 498 ARG B 503 SITE 5 AC7 18 HOH B 717 HOH B 794 SITE 1 AC8 4 SER B 84 VAL B 85 ARG B 120 HOH B 854 SITE 1 AC9 3 ARG B 48 LYS B 51 CYS B 223 SITE 1 BC1 3 GLY B 516 ARG B 517 HOH B 824 SITE 1 BC2 4 SER A 1 LYS B 379 ARG B 380 HOH B 846 SITE 1 BC3 3 HIS B 475 SER B 476 HOH B 783 CRYST1 66.300 91.400 231.700 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004316 0.00000